In 2005, the heads of the European medicines agencies agreed that all EU member states must have the infrastructure and processes in place to handle only electronic Common Technical Document (eCTD) ...
How to cut time and cost by re-using already submitted documents. Increasing drug-development costs, patent expirations, and fewer blockbuster drugs in the pipeline are forcing life-science companies ...
All regions that have published guidelines will mandate implementation of eCTD version 4.0 by 2028, with more regions to follow in the future Developed by the International Council for Harmonisation ...
The US Food and Drug Administration (FDA) on Monday revised its guidance on the electronic common technical document (eCTD) format to note specific cases where the agency believes a submission should ...
Updating the eCTD The move from the current version, eCTD v3.2.2, to v4.0 is being driven by several needs and improvements identified over the past several years. To facilitate more streamlined ...
The main market opportunity lies in understanding and leveraging evolving regulatory requirements and regional initiatives like CTD and eCTD submissions in the dynamic pharmaceutical landscape of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results